The US IPO market saw plenty of activity this week, as issuers move to adapt to the ongoing government shutdown. Six IPOs debuted this week, while two SPACs listed. Thirteen IPOs and Five SPACs also submitted initial filings. Commercial washing machine...read more
Turn Therapeutics, which is developing drugs and medical products for the wound and dermatology markets, announced last week that it had received approval to list its shares on the Nasdaq and expects trading to commence today, 10/8. The company registered...read more
One small IPO and two SPACs debuted this week. Nine IPOs and four SPACs submitted initial filings. Singapore-based swim lesson provider Fitness Champs Holdings (FCHL) priced its US IPO at the bottom of the range to raise $15 million at a $68 million market...read more
Turn Therapeutics, which is developing drugs and medical products for the wound and dermatology markets, filed on Tuesday to register its shares with the SEC and complete a direct listing on the Nasdaq. The shares of common stock will be sold by existing...read more
US IPO Weekly Recap: 6 IPOs debut, pipeline grows, despite government shutdown
The US IPO market saw plenty of activity this week, as issuers move to adapt to the ongoing government shutdown. Six IPOs debuted this week, while two SPACs listed. Thirteen IPOs and Five SPACs also submitted initial filings. Commercial washing machine...read more
Wound and dermatology-focused Turn Therapeutics set to direct list on the Nasdaq today, 10/8
Turn Therapeutics, which is developing drugs and medical products for the wound and dermatology markets, announced last week that it had received approval to list its shares on the Nasdaq and expects trading to commence today, 10/8. The company registered...read more
US IPO Weekly Recap: 1 small IPO debuts as more filers enter the pipeline
One small IPO and two SPACs debuted this week. Nine IPOs and four SPACs submitted initial filings. Singapore-based swim lesson provider Fitness Champs Holdings (FCHL) priced its US IPO at the bottom of the range to raise $15 million at a $68 million market...read more
Wound and dermatology-focused Turn Therapeutics files for a direct listing on the Nasdaq
Turn Therapeutics, which is developing drugs and medical products for the wound and dermatology markets, filed on Tuesday to register its shares with the SEC and complete a direct listing on the Nasdaq. The shares of common stock will be sold by existing...read more